Nosocomial Influenza Surveillance 2018 - 2022

Influenza Clinical Trial

— NOSOGRIPPE  

Official title:

Surveillance of Nosocomial Influenza at Edouard Herriot University Hospital, Lyon, France.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03413228
• Other study ID #: 69HCL17_0868
• Status: Not yet recruiting
• Phase: N/A
• First received: January 22, 2018
• Last updated: January 26, 2018
• Start date: February 2018
• Est. completion date: June 2022

Study information

• Verified date: January 2018
• Source: Hospices Civils de Lyon
• Contact: Philippe VANHEMS, MD PhD
• Phone: 0472110719
• Email: philippe.vanhems[@]chu-lyon.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hospital-acquired influenza is associated with significant morbidity and mortality in hospitalized patients notably elderly patients. Furthermore, it is also associated with a large economic impact for the hospitals.

The transmission of influenza has been mostly reported in pediatric and long-stay units. The chains of transmission of influenza in acute-stay units have to be describe in order to prevent and control potential outbreaks. Furthermore, to know clinical symptoms seems to be important in order to identify potential sources of virus as soon as possible and to set up appropriate hygiene prevention measures. Moreover, the definition of the hospital-acquired influenza has to be harmonized for all over the studies, especially concerning the delay between the admission in the hospital and the symptoms onset.

The aim of this study is to describe the hospital-acquired influenza in a french university hospital of around 800 beds

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: June 2022
• Est. primary completion date: June 2018
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult patients and health-care workers in a participating unit in the study,

• more than 18 years old,

• volunteers,

• who present an influenza-like illness defined by fever > 37,8°C or/and cough or sore throat.

Exclusion Criteria:

-Everyone who does not present the inclusion criteria.

Related Conditions & MeSH terms

• Cross Infection
• Hospital-Acquired Infection
• Influenza
• Influenza, Human

Intervention

Other:
• Questionnaire
An interview to collect some informations will be done: demographic informations, medical history, vaccination against influenza status, symptoms and virological informations. Then, a nasal swab was performed in order to identified the influenza virus.

Locations

Country	Name	City	State
France	Infection Control unit. Edouard Herriot hospital Lyon - France	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patients and health-care workers who present an influenza illness.	An interview to collect some informations will be done to evaluate if participants present symptoms of an inflenza illness (fever > 37,8°C or/and cough or sore throat).; Then, a nasal swab will be performed in order to identified the influenza virus.	5 days maximum